Literature DB >> 8922800

Slowly growing mycobacteria and chronic skin disorders.

J O Mattila1, M L Katila, M Vornanen.   

Abstract

We evaluated the role of mycobacteria in chronic skin manifestations. The etiologies of chronic skin disorders in 90 patients were analyzed by culture, histopathologic examination, and skin testing for mycobacteria. There were 20 clinical diagnoses; prurigo nodularis was the most common diagnosis (43 patients). Cultures were incubated at 32 degrees C and 36 degrees C for 6 months. Fourteen cultures (16%) yielded the following mycobacteria: Mycobacterium tuberculosis (5), Mycobacterium avium/Mycobacterium intracellulare complex (3), Mycobacterium malmoense (2), and other mycobacteria (4). Acid-fast bacilli were detected in 24 (28%) of the 86 histopathologic specimens examined, including nine of the 14 culture-positive specimens. Granulomatous infection was present in three specimens (3%); cultures of two of these specimens yielded M. tuberculosis, and culture of one was negative. Skin reactivity to 12 mycobacterial antigens was tested. The patients for whom staining and/or culture was positive for mycobacteria had significantly larger skin reactions to M. malmoense antigen (P < .001) than did the patients with bacteriologically negative skin disorders. There was no correlation between the species isolated and the skin reactivity to the species-specific antigen.

Entities:  

Mesh:

Year:  1996        PMID: 8922800     DOI: 10.1093/clinids/23.5.1043

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  2 in total

1.  Characterization of Mycobacterium bohemicum isolated from human, veterinary, and environmental sources.

Authors:  P Torkko; S Suomalainen; E Iivanainen; M Suutari; L Paulin; E Rudbäck; E Tortoli; V Vincent; R Mattila; M L Katila
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

2.  Accelerated detection and identification of mycobacteria with MGIT 960 and COBAS AMPLICOR systems.

Authors:  M L Katila; P Katila; R Erkinjuntti-Pekkanen
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.